Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Accenture
Covington
Johnson and Johnson
Cantor Fitzgerald
Cerilliant
Moodys
Fuji
Harvard Business School

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANDROGEL

« Back to Dashboard

Clinical Trials for Androgel

Trial ID Title Status Sponsor Phase Summary
NCT00112151 TEAM: Testosterone Supplementation and Exercise in Elderly Men Completed National Institute on Aging (NIA) Phase 2 The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00112151 TEAM: Testosterone Supplementation and Exercise in Elderly Men Completed University of Colorado, Denver Phase 2 The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Men Recruiting AbbVie N/A The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Men Recruiting AstraZeneca N/A The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Men Recruiting National Institute on Aging (NIA) N/A The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Men Recruiting Solvay Pharmaceuticals N/A The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Men Recruiting Massachusetts General Hospital N/A The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Androgel

Condition Name

Condition Name for Androgel
Intervention Trials
Hypogonadism 8
Secondary Hypogonadism 4
Healthy 3
Insulin Resistance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Androgel
Intervention Trials
Hypogonadism 17
Diabetes Mellitus, Type 2 3
Insulin Resistance 3
Diabetes Mellitus 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Androgel

Trials by Country

Trials by Country for Androgel
Location Trials
United States 103
Canada 7
Germany 2
Israel 2
Netherlands 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Androgel
Location Trials
New York 11
Texas 9
Washington 8
California 8
Florida 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Androgel

Clinical Trial Phase

Clinical Trial Phase for Androgel
Clinical Trial Phase Trials
Phase 4 7
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Androgel
Clinical Trial Phase Trials
Completed 22
Not yet recruiting 6
Terminated 2
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Androgel

Sponsor Name

Sponsor Name for Androgel
Sponsor Trials
Solvay Pharmaceuticals 9
Repros Therapeutics Inc. 4
University of Washington 4
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Androgel
Sponsor Trials
Other 30
Industry 25
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cerilliant
Colorcon
Harvard Business School
Moodys
Farmers Insurance
Merck
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.